Pomalidomide Capsule
Product Images NDC 59651-196

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 59651-196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pomalidomide Fig1)

Description: The text provides statistical information comparing two treatment groups (POM-LD-DEX and HD-DEX) in a study, displaying the logrank p-value, Kaplan-Meier medians, number of events, proportions of subjects at risk, and the number of subjects in each group. The results indicate a significant difference between the two groups with respect to survival and treatments received.*

FDA Label Image

Package Label-principal Display Panel (4 mg (100 Capsules Bottle))

This text is the label for Pomalidomide Capsules, with a warning about the potential for human birth defects. It includes instructions for the pharmacist to dispense the medication guide, information on the content of the capsules, storage instructions, details about the manufacturer (Aurobindo Pharma USA, Inc.), and the dosage guidance. It specifies that each capsule contains 4 mg of pomalidomide and recommends checking the prescribing information for dosing and administration guidance.*

FDA Label Image

Figure 2 (Pomalidomide Fig2)

FDA Label Image

Package Label-principal Display Panel (1 mg (21 Capsules Bottle))

The text describes a medication called Pomalidomide Capsules, with each capsule containing 1mg of pomalidomide. It warns about the potential for human birth defects and advises pharmacists to dispense the Medication Guide provided separately to each patient. The usual dosage instructions are to be followed as per the prescribing information for dosing and administration. The medication is distributed by Aurobindo Pharma USA, Inc. and should be stored at 20° to 25°C.*

FDA Label Image

Package Label-principal Display Panel (1 mg (100 Capsules Bottle))

This is a description of Pomalidomide Capsules, each containing 1 mg of pomalidomide. It carries a warning about the potential for human birth defects and should only be dispensed with a medication guide. The usual dosage information is available in the prescribing information. The capsules should be stored at 20°C to 25°C. The product is distributed by Aurobindo Pharma USA, Inc. and is made in India. The packaging includes a National Drug Code (NDC) for identification.*

FDA Label Image

Package Label-principal Display Panel (2 mg (21 Capsules Bottle))

This is information about Pomalidomide Capsules containing 2 mg of pomalidomide, with a warning about the potential for human birth defects. The medication guide should be dispensed to each patient. The usual dosage can be found in the prescribing information. The capsules should be stored at 20°C to 25°C. The product is distributed by Aurobindo Pharma USA, Inc. Made in India.*

FDA Label Image

Package Label-principal Display Panel (2 mg (100 Capsules Bottle))

This text is a description of a medication labeled with the NDC 59651-195-01, which contains 2 mg of pomalidomide per capsule. It provides information on the usual dosage and storage conditions. There is also a warning regarding the potential for human birth defects. The medication is manufactured by Aurobindo Pharma USA, Inc. and comes with a guide for each patient. Additionally, it mentions the address of the company and specifies that it is made in India.*

FDA Label Image

Package Label-principal Display Panel (3 mg (21 Capsules Bottle))

This text presents information about Pomalidomide Capsules in a dosage strength of 3mg. It includes a warning about the potential for human birth defects. The medication should be dispensed with a Medication Guide provided separately to each patient. The usual dosage is 3mg per capsule. The prescribing information should be consulted for dosing and administration instructions. The medication should be stored at 20°C to 25°C (68°F to 77°F). The capsules are distributed by Aurobindo Pharma USA, Inc. and made in India. The text also includes various codes and a note about not printing certain dotted lines.*

FDA Label Image

Package Label-principal Display Panel (3 mg (100 Capsules Bottle))

Each capsule of NDG 59651-196-01 contains 3 mg of pomalidomide. The usual dosage for Pomalidomide Capsules should be referred to the prescribing information for dosing and administration guidelines. Store the capsules at a temperature between 20°C to 25°C (68°F to 77°F). A warning is provided regarding the potential for human birth defects. The medication is dispensed by Aurobindo Pharma USA, Inc. in East Windsor, NJ. The capsules are made in India. The package contains 100 capsules.*

FDA Label Image

Package Label-principal Display Panel (4 mg (21 Capsules Bottle))

This text provides information about a medication called Pomalidomide. Each capsule contains 4 mg of the active ingredient. The usual dosage, prescribing information, and administration details are not provided in this snippet, but it advises referring to the prescribing information for dosing guidance. It is recommended to store the capsules at a temperature between 20°C to 25°C. The text also includes a warning about the potential for human birth defects and details about the manufacturer, Aurobindo Pharma USA, Inc. The label indicates that the medication is for prescription use only, is made in India, and includes a code for identification purposes.*

FDA Label Image

Chemical Structure (Pomalidomide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.